Target intelligence / Profile preview

Ribosomal protein L37 pseudogene 10 (RPL37P10)

Target
RPL37P10
Molecular classification
Processed pseudogene, family of ribosomal protein pseudogenes
01

Overview

Ribosomal protein L37 pseudogene 10 (RPL37P10) is a processed pseudogene in the human genome, located on chromosome 2, that is homologous to the protein-coding RPL37 gene. Unlike the functional RPL37 gene—which encodes a component of the 60S ribosomal subunit involved in protein synthesis—RPL37P10 does not produce a functional protein product. Pseudogenes such as RPL37P10 arise from gene duplication or retrotransposition events and typically lack biological function, coding potential, or relevance as drug targets. This is not considered a therapeutic target, as it is a pseudogene without evidence of expression of a functional protein or established biological/medical role. RPL37P10 is a non-functional genomic sequence; it is not an active, protein-coding target and does not meet the criteria for molecules typically categorized as drug targets, receptors, enzymes, or transporters—this makes it inappropriate for conventional target-based drug discovery. There is no evidence in curated databases or scientific literature for any biological function, disease association, drug interaction, mechanism of action, biomarker potential, or safety concern specific to RPL37P10. All available evidence classifies it solely as a nonfunctional genomic element. RPL37P10 is one of many processed pseudogenes in the human genome related to ribosomal protein genes. It is homologous to RPL37, a gene encoding a constituent of the ribosomal large subunit, but lacks exons and regulatory regions required for expression of a functional protein. As such, it is considered biologically inert and not relevant for therapeutic targeting or disease biomarker development. If you require information about the functional protein (RPL37), see entries under "Ribosomal protein L37" instead.

Other names
RPL37_2_245RPL37P10

Beyond the preview

Go deeper on Ribosomal protein L37 pseudogene 10 (RPL37P10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L37 pseudogene 10 (RPL37P10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call